RKDA Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

1.40M

+15.13%

-0.660

-77.93%

1.60M

+33.33%

-0.800

-142.11%

1.90M

+30.58%

-0.560

-82.82%

Estimates Revision

The market is revising No Change the revenue expectations for Arcadia Biosciences, Inc. (RKDA) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -41.67%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-41.67%

In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Arcadia Biosciences Inc (RKDA.O) is -0.87, compared to its 5-year average forward P/E of -1.68. For a more detailed relative valuation and DCF analysis to assess Arcadia Biosciences Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-1.68

Current PE

-0.87

Overvalued PE

-0.52

Undervalued PE

-2.84

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.20

Current EV/EBITDA

0.89

Overvalued EV/EBITDA

1.21

Undervalued EV/EBITDA

-0.81

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

1.62

Current PS

0.40

Overvalued PS

3.38

Undervalued PS

-0.15

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

RKDA News & Events

Events Timeline

No data

News

4.5

2025-12-26NASDAQ.COM

Arcadia Biosciences (RKDA) Terminates Agreement with Roosevelt Resources, Resumes Strategic Evaluation

4.5

2025-12-26Globenewswire

Arcadia Biosciences Terminates Agreement with Roosevelt Resources, Resumes Strategic Evaluation

3.5

2025-12-04Newsfilter

Rigaku Launches XTRAIA MF-3400 for Semiconductor Measurement, Anticipates Over JPY 6 Billion Sales by 2026

People Also Watch

Frequently Asked Questions

What is Arcadia Biosciences Inc (RKDA) stock price today?

The current price of RKDA is 2.59 USD — it has increased 7.47 % in the last trading day.

What is Arcadia Biosciences Inc (RKDA)'s business?

Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.

What is the price predicton of RKDA Stock?

Wall Street analysts forecast RKDA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for RKDA is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Arcadia Biosciences Inc (RKDA)'s revenue for the last quarter?

Arcadia Biosciences Inc revenue for the last quarter amounts to 1.30M USD, decreased -15.29 % YoY.

What is Arcadia Biosciences Inc (RKDA)'s earnings per share (EPS) for the last quarter?

Arcadia Biosciences Inc. EPS for the last quarter amounts to 0.62 USD, decreased -152.54 % YoY.

What changes have occurred in the market's expectations for Arcadia Biosciences Inc (RKDA)'s fundamentals?

How many employees does Arcadia Biosciences Inc (RKDA). have?

Arcadia Biosciences Inc (RKDA) has 9 emplpoyees as of January 08 2026.

What is Arcadia Biosciences Inc (RKDA) market cap?

Today RKDA has the market capitalization of 3.22M USD.